316 related articles for article (PubMed ID: 11960982)
41. Modulation of rat erg1, erg2, erg3 and HERG K+ currents by thyrotropin-releasing hormone in anterior pituitary cells via the native signal cascade.
Schledermann W; Wulfsen I; Schwarz JR; Bauer CK
J Physiol; 2001 Apr; 532(Pt 1):143-63. PubMed ID: 11283231
[TBL] [Abstract][Full Text] [Related]
42. Transfer of rapid inactivation and sensitivity to the class III antiarrhythmic drug E-4031 from HERG to M-eag channels.
Herzberg IM; Trudeau MC; Robertson GA
J Physiol; 1998 Aug; 511 ( Pt 1)(Pt 1):3-14. PubMed ID: 9679158
[TBL] [Abstract][Full Text] [Related]
43. High affinity open channel block by dofetilide of HERG expressed in a human cell line.
Snyders DJ; Chaudhary A
Mol Pharmacol; 1996 Jun; 49(6):949-55. PubMed ID: 8649354
[TBL] [Abstract][Full Text] [Related]
44. Cocaine blocks HERG, but not KvLQT1+minK, potassium channels.
Zhang S; Rajamani S; Chen Y; Gong Q; Rong Y; Zhou Z; Ruoho A; January CT
Mol Pharmacol; 2001 May; 59(5):1069-76. PubMed ID: 11306689
[TBL] [Abstract][Full Text] [Related]
45. The antipsychotic agent sertindole is a high affinity antagonist of the human cardiac potassium channel HERG.
Rampe D; Murawsky MK; Grau J; Lewis EW
J Pharmacol Exp Ther; 1998 Aug; 286(2):788-93. PubMed ID: 9694935
[TBL] [Abstract][Full Text] [Related]
46. Mechanism of block and identification of the verapamil binding domain to HERG potassium channels.
Zhang S; Zhou Z; Gong Q; Makielski JC; January CT
Circ Res; 1999 May; 84(9):989-98. PubMed ID: 10325236
[TBL] [Abstract][Full Text] [Related]
47. Blockade of HERG channels expressed in Xenopus laevis oocytes by external divalent cations.
Ho WK; Kim I; Lee CO; Youm JB; Lee SH; Earm YE
Biophys J; 1999 Apr; 76(4):1959-71. PubMed ID: 10096894
[TBL] [Abstract][Full Text] [Related]
48. Regulation of deactivation by an amino terminal domain in human ether-à-go-go-related gene potassium channels.
Wang J; Trudeau MC; Zappia AM; Robertson GA
J Gen Physiol; 1998 Nov; 112(5):637-47. PubMed ID: 9806971
[TBL] [Abstract][Full Text] [Related]
49. Kinetic modulation of HERG potassium channels by the volatile anesthetic halothane.
Li J; Correa AM
Anesthesiology; 2002 Oct; 97(4):921-30. PubMed ID: 12357160
[TBL] [Abstract][Full Text] [Related]
50. Blockade of the human ether-a-go-go-related gene potassium channel by ketanserin.
Tu DN; Zou AR; Liao YH; Du YM; Wang XP; Li L
Sheng Li Xue Bao; 2008 Aug; 60(4):525-34. PubMed ID: 18690396
[TBL] [Abstract][Full Text] [Related]
51. Saxitoxin is a gating modifier of HERG K+ channels.
Wang J; Salata JJ; Bennett PB
J Gen Physiol; 2003 Jun; 121(6):583-98. PubMed ID: 12771193
[TBL] [Abstract][Full Text] [Related]
52. Mapping the binding site of a human ether-a-go-go-related gene-specific peptide toxin (ErgTx) to the channel's outer vestibule.
Pardo-Lopez L; Zhang M; Liu J; Jiang M; Possani LD; Tseng GN
J Biol Chem; 2002 May; 277(19):16403-11. PubMed ID: 11864985
[TBL] [Abstract][Full Text] [Related]
53. Inhibition of cardiac potassium currents by pentobarbital.
Bachmann A; Mueller S; Kopp K; Brueggemann A; Suessbrich H; Gerlach U; Busch AE
Naunyn Schmiedebergs Arch Pharmacol; 2002 Jan; 365(1):29-37. PubMed ID: 11862331
[TBL] [Abstract][Full Text] [Related]
54. Inhibition of HERG potassium channel current by the class 1a antiarrhythmic agent disopyramide.
Paul AA; Witchel HJ; Hancox JC
Biochem Biophys Res Commun; 2001 Feb; 280(5):1243-50. PubMed ID: 11162661
[TBL] [Abstract][Full Text] [Related]
55. Characterisation of recombinant HERG K+ channel blockade by the Class Ia antiarrhythmic drug procainamide.
Ridley JM; Milnes JT; Benest AV; Masters JD; Witchel HJ; Hancox JC
Biochem Biophys Res Commun; 2003 Jun; 306(2):388-93. PubMed ID: 12804575
[TBL] [Abstract][Full Text] [Related]
56. Structural determinants of HERG channel block by clofilium and ibutilide.
Perry M; de Groot MJ; Helliwell R; Leishman D; Tristani-Firouzi M; Sanguinetti MC; Mitcheson J
Mol Pharmacol; 2004 Aug; 66(2):240-9. PubMed ID: 15266014
[TBL] [Abstract][Full Text] [Related]
57. Interactions of the 5-hydroxytryptamine 3 antagonist class of antiemetic drugs with human cardiac ion channels.
Kuryshev YA; Brown AM; Wang L; Benedict CR; Rampe D
J Pharmacol Exp Ther; 2000 Nov; 295(2):614-20. PubMed ID: 11046096
[TBL] [Abstract][Full Text] [Related]
58. Fenamate-induced enhancement of heterologously expressed HERG currents in Xenopus oocytes.
Malykhina AP; Shoeb F; Akbarali HI
Eur J Pharmacol; 2002 Oct; 452(3):269-77. PubMed ID: 12359267
[TBL] [Abstract][Full Text] [Related]
59. Voltage-shift of the current activation in HERG S4 mutation (R534C) in LQT2.
Nakajima T; Furukawa T; Hirano Y; Tanaka T; Sakurada H; Takahashi T; Nagai R; Itoh T; Katayama Y; Nakamura Y; Hiraoka M
Cardiovasc Res; 1999 Nov; 44(2):283-93. PubMed ID: 10690305
[TBL] [Abstract][Full Text] [Related]
60. Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature.
Zhou Z; Gong Q; Ye B; Fan Z; Makielski JC; Robertson GA; January CT
Biophys J; 1998 Jan; 74(1):230-41. PubMed ID: 9449325
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
